DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
02 1DEXMETHYLPHENIDATE HYDROCHLORIDE
03 1HYDROMORPHONE HYDROCHLORIDE
04 1KYNMOBI
05 2LANSOPRAZOLE
06 1METFORMIN HYDROCHLORIDE
07 2METHYLPHENIDATE HYDROCHLORIDE
08 2OMEPRAZOLE
01 121704
02 175757
03 178458
04 191352
05 1200886
06 1201921
07 1203306
08 1209993
09 1210875
10 1212133
11 1215523
01 10No
02 1Yes
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78458
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 200886
Country : US
Patented : No
Drug : HYDROMORPHONE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 212133
Country : US
Patented : No
DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug : DEXMETHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 215523
Country : US
Patented : No
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Drug : ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21704
Country : US
Patented : No
Drug : LANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 201921
Country : US
Patented : No
Drug : LANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 203306
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 209993
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 75757
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 91352
Country : US
Patented : No
LOOKING FOR A SUPPLIER?